26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
The CARES Act Paycheck Protection Program (“PPP”) has provided much needed assistance to millions ...
Read More >
Quick Hit: On June 28, 2019 The Office of Management and Budget (“OMB”) published notice that “OF...
Read More >
On January 31, 2019, U.S. Citizenship and Immigration Services (USCIS) issued a final rule making si...
Read More >
On November 8, 2019, Governor Andrew Cuomo signed new legislation adding Section 203-e to the New Yo...
Read More >
Orrick’s Equal Pay Pulse has been tracking the nationwide wave of salary history bans in recent yea...
Read More >
The U.S. Department of Labor is still working to finalize the withdrawal of the 80/20 rule, which ha...
Read More >